Výsledky vyhledávání

Combined therapies with nanostructured carbon materials: there is room still available at the bottom

Autor: Biagiotti, G. Fedeli, S. Tuci, G. Luconi, L. Giambastiani, G. Brandi, A. Pisaneschi, F. Cicchi, S. Paoli

Publikováno v: Journal of Materials Chemistry B 6 (2018). doi:10.1039/c8tb00121a
info:cnr-pdr/source/autori:Biagiotti, G. Fedeli, S. Tuci, G. Luconi, L. Giambastiani, G. Brandi, A. Pisaneschi, F. Cicchi, S. Paoli, P./titolo:Combined therapies with nanostructured carbon materials: there is room still left at the bottom/doi:10.1039%2Fc8tb00121a/rivista:Journal of Materials Chemistry B/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:6

The progress of the chemistry of carbon nanotubes (CNT) and graphene derivatives [mainly graphene oxide (GO)] has produced a number of technologically advanced drug delivery systems (DDS) that have been used in the field of nanomedicine, mostly in st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c99b888fbd99f3ed8cc5fc8ed7e75cf
https://pubmed.ncbi.nlm.nih.gov/32254426

Zobrazit plný text záznamu

Akademický článek

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

Autor: F. F. Pepe, M. E. Cazzaniga, S. Baroni, F. Riva, F. Cicchiello, S. Capici, V. Cogliati, C. Maggioni, N. Cordani, M. G. Cerrito, S. Malandrin

Publikováno v: BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)

Abstract Tregs are able of suppressing tumor-specific effector cells, such as lymphocytes CD8+, CD4+ and Natural Killer cells. Different drugs, especially different schedules of administration, like metronomic chemotherapy (mCHT), seem to be able to

Externí odkaz: https://doaj.org/article/d6c55507aba744ac89504316a2e8b907

Zobrazit plný text záznamu

Akademický článek

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Autor: M. E. Cazzaniga, L. Cortesi, A. Ferzi, L. Scaltriti, F. Cicchiello, M. Ciccarese, S. Della Torre, F. Villa, M. Giordano, C. Verusio, M. Nicolini, A. R. Gambaro, L. Zanlorenzi, E. Biraghi, E. Casini, L. Legramandi, E. Rulli

Publikováno v: International Journal of Breast Cancer, Vol 2017 (2017)

Triple-negative breast cancer (TNBC) shows a very bad prognosis, even in early stages of disease. Metronomic chemotherapy refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen with no prolonged

Externí odkaz: https://doaj.org/article/a530eb83e98140638779f75caa91f5b0

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání